260 related articles for article (PubMed ID: 36183165)
1. Comparison of diagnostic performances of different serological tests for SARS-CoV-2 antibody detection in cats and dogs.
Ratti G; Lelli D; Moreno A; Stranieri A; Trogu T; Giordano A; Grassi A; Luzzago C; Decaro N; Paltrinieri S; Lauzi S
Transbound Emerg Dis; 2022 Nov; 69(6):3530-3539. PubMed ID: 36183165
[TBL] [Abstract][Full Text] [Related]
2. Serological survey of antibodies against SARS-CoV-2 in dogs and cats, Thailand.
Udom K; Jairak W; Chamsai E; Charoenkul K; Boonyapisitsopa S; Bunpapong N; Techakriengkrai N; Amonsin A
Transbound Emerg Dis; 2022 Jul; 69(4):2140-2147. PubMed ID: 34180590
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA.
Dileepan M; Di D; Huang Q; Ahmed S; Heinrich D; Ly H; Liang Y
Virulence; 2021 Dec; 12(1):1597-1609. PubMed ID: 34125647
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of anti-severe acute respiratory syndrome coronavirus 2 antibodies in cats in Germany and other European countries in the early phase of the coronavirus disease-19 pandemic.
Adler JM; Weber C; Wernike K; Michelitsch A; Friedrich K; Trimpert J; Beer M; Kohn B; Osterrieder K; Müller E
Zoonoses Public Health; 2022 Aug; 69(5):439-450. PubMed ID: 35238485
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies.
James J; Rhodes S; Ross CS; Skinner P; Smith SP; Shipley R; Warren CJ; Goharriz H; McElhinney LM; Temperton N; Wright E; Fooks AR; Clark TW; Brookes SM; Brown IH; Banyard AC
Viruses; 2021 Apr; 13(4):. PubMed ID: 33924168
[TBL] [Abstract][Full Text] [Related]
6. Long-term persistence of neutralizing SARS-CoV-2 antibodies in pets.
Decaro N; Grassi A; Lorusso E; Patterson EI; Lorusso A; Desario C; Anderson ER; Vasinioti V; Wastika CE; Hughes GL; Valleriani F; Colitti B; Ricci D; Buonavoglia D; Rosati S; Cavaliere N; Paltrinieri S; Lauzi S; Elia G; Buonavoglia C
Transbound Emerg Dis; 2022 Sep; 69(5):3073-3076. PubMed ID: 34469620
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera.
Perera RAPM; Ko R; Tsang OTY; Hui DSC; Kwan MYM; Brackman CJ; To EMW; Yen HL; Leung K; Cheng SMS; Chan KH; Chan KCK; Li KC; Saif L; Barrs VR; Wu JT; Sit THC; Poon LLM; Peiris M
J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139421
[TBL] [Abstract][Full Text] [Related]
8. Serological evidence of SARS-CoV-2 infection in pets naturally exposed during the COVID-19 outbreak in Argentina.
Panei CJ; Bravi ME; Moré G; De Felice L; Unzaga JM; Salina M; Rivero FD; Di Lullo D; Pecoraro M; Alvarez D; Castro E; Fuentealba NA
Vet Immunol Immunopathol; 2022 Dec; 254():110519. PubMed ID: 36434944
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance between in-house and commercial SARS-CoV-2 serological immunoassays including binding-specific antibody and surrogate virus neutralization test (sVNT).
Winichakoon P; Wipasa J; Chawansuntati K; Salee P; Sudjaritruk T; Yasri S; Khamwan C; Peerakam R; Dankai D; Chaiwarith R
Sci Rep; 2023 Jan; 13(1):34. PubMed ID: 36593231
[TBL] [Abstract][Full Text] [Related]
10. Performance evaluation of four surrogate Virus Neutralization Tests (sVNTs) in comparison to the
Pieri M; Infantino M; Manfredi M; Nuccetelli M; Grossi V; Lari B; Tomassetti F; Sarubbi S; Russo E; Amedei A; Benucci M; Casprini P; Stacchini L; Castilletti C; Bernardini S
Front Biosci (Landmark Ed); 2022 Feb; 27(2):74. PubMed ID: 35227017
[TBL] [Abstract][Full Text] [Related]
11. Serological Screening for Antibodies against SARS-CoV-2 in Dutch Shelter Cats.
van der Leij WJR; Broens EM; Hesselink JW; Schuurman N; Vernooij JCM; Egberink HF
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452497
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to SARS-CoV-2 in dogs and cats, USA.
Barua S; Hoque M; Adekanmbi F; Kelly P; Jenkins-Moore M; Torchetti MK; Chenoweth K; Wood T; Wang C
Emerg Microbes Infect; 2021 Dec; 10(1):1669-1674. PubMed ID: 34374631
[TBL] [Abstract][Full Text] [Related]
13. Low Prevalence of SARS-CoV-2 Antibodies in Canine and Feline Serum Samples Collected during the COVID-19 Pandemic in Hong Kong and Korea.
Go YY; Carrai M; Choi YR; Brackman CJ; Tam KWS; Law PYT; Woodhouse F; Gray J; Kim JH; Park J; Jeon CW; Jang H; Magouras I; Decaro N; Cheng SMS; Peiris M; Beatty JA; Barrs VR
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851796
[TBL] [Abstract][Full Text] [Related]
14. Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study.
Horn MP; Jonsdottir HR; Brigger D; Damonti L; Suter-Riniker F; Endrich O; Froehlich TK; Fiedler M; Largiadèr CR; Marschall J; Weber B; Eggel A; Nagler M
Allergy; 2022 Jul; 77(7):2090-2103. PubMed ID: 34986501
[TBL] [Abstract][Full Text] [Related]
15. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.
Nicholson S; Karapanagiotidis T; Khvorov A; Douros C; Mordant F; Bond K; Druce J; Williamson DA; Purcell D; Lewin SR; Sullivan S; Subbarao K; Catton M
Open Forum Infect Dis; 2021 Jul; 8(7):ofab239. PubMed ID: 34258311
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T
J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695
[TBL] [Abstract][Full Text] [Related]
18. Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays.
Valcourt EJ; Manguiat K; Robinson A; Lin YC; Abe KT; Mubareka S; Shigayeva A; Zhong Z; Girardin RC; DuPuis A; Payne A; McDonough K; Wang Z; Gasser R; Laumaea A; Benlarbi M; Richard J; Prévost J; Anand SP; Dimitrova K; Phillipson C; McGeer A; Gingras AC; Liang C; Petric M; Sekirov I; Morshed M; Finzi A; Drebot M; Wood H
Microbiol Spectr; 2021 Dec; 9(3):e0088621. PubMed ID: 34787495
[TBL] [Abstract][Full Text] [Related]
19. Correlation between In Vitro Neutralization Assay and Serological Tests for Protective Antibodies Detection.
Bonifacio MA; Laterza R; Vinella A; Schirinzi A; Defilippis M; Di Serio F; Ostuni A; Fasanella A; Mariggiò MA
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076960
[TBL] [Abstract][Full Text] [Related]
20. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.
Meschi S; Colavita F; Bordi L; Matusali G; Lapa D; Amendola A; Vairo F; Ippolito G; Capobianchi MR; Castilletti C;
J Clin Virol; 2020 Aug; 129():104539. PubMed ID: 32679298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
